Response to Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia

Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research